XML 70 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Borrowings
12 Months Ended
Dec. 31, 2019
Borrowings [Abstract]  
Borrowings

NOTE 10 – BORROWINGS



The Company’s borrowings at December 31, 2019 and 2018, net of deferred financing costs and incorporating the impact of interest rate swaps on our effective interest rates, are summarized below:







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

As of December 31, 2019

(Dollars in thousands)

 

Maturity Date

 

Contractual
Facility

 

Balance,
Gross

 

Balance,
Net(1)

 

Stated
Interest
Rate

 

Effective
Interest
Rate

Denominated in USD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trust Preferred Securities (USA)

 

April 30, 2027

 

$

27,913 

 

$

27,913 

 

$

26,311 

 

5.94%

 

5.94%

Bank of America Credit Facility (USA)

 

March 6, 2023

 

 

55,000 

 

 

33,500 

 

 

33,445 

 

4.80%

 

4.80%

Bank of America Line of Credit (USA)

 

March 6, 2023

 

 

5,000 

 

 

 —

 

 

 —

 

4.80%

 

4.80%

Cinemas 1, 2, 3 Term Loan (USA)

 

April 1, 2022

 

 

18,658 

 

 

18,658 

 

 

18,532 

 

3.25%

 

3.25%

Minetta & Orpheum Theatres Loan (USA)(2)

 

November 1, 2023

 

 

8,000 

 

 

8,000 

 

 

7,887 

 

3.74%

 

5.15%

U.S. Corporate Office Term Loan (USA)

 

January 1, 2027

 

 

9,260 

 

 

9,260 

 

 

9,153 

 

4.64% / 4.44%

 

4.64%

Union Square Construction Financing (USA)

 

December 29, 2020

 

 

50,000 

 

 

36,048 

 

 

36,035 

 

6.02%

 

6.02%

Purchase Money Promissory Note

 

September 18, 2024

 

 

3,363 

 

 

3,363 

 

 

3,363 

 

5.00%

 

5.00%

Denominated in foreign currency ("FC")(3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NAB Corporate Term Loan (AU)

 

December 31, 2023

 

 

84,360 

 

 

65,731 

 

 

65,541 

 

1.77%

 

1.77%

Westpac Bank Corporate (NZ)

 

December 31, 2023

 

 

21,584 

 

 

6,745 

 

 

6,745 

 

3.05%

 

3.05%

Total

 

 

 

$

283,138 

 

$

209,218 

 

$

207,012 

 

 

 

 



(1)

Net of deferred financing costs amounting to $2.2 million.

(2)

The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%.

(3)

The contractual facilities and outstanding balances of the FC-denominated borrowings were translated into U.S. dollars based on exchange rates as of December 31, 2019.





 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

As of December 31, 2018

(Dollars in thousands)

 

Maturity Date

 

Contractual
Facility

 

Balance,
Gross

 

Balance,
Net(1)

 

Stated
Interest
Rate

 

Effective
Interest
Rate

Denominated in USD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trust Preferred Securities (USA)

 

April 30, 2027

 

$

27,913 

 

$

27,913 

 

$

26,061 

 

6.52%

 

6.52%

Bank of America Credit Facility (USA)

 

May 1, 2020

 

 

55,000 

 

 

25,000 

 

 

25,000 

 

5.02%

 

5.02%

Bank of America Line of Credit (USA)

 

October 31, 2019

 

 

5,000 

 

 

 —

 

 

 —

 

5.48%

 

5.48%

Banc of America digital projector loan (USA)

 

December 28, 2019

 

 

2,604 

 

 

2,604 

 

 

2,604 

 

5.00%

 

5.00%

Cinema 1, 2, 3 Term Loan (USA)

 

September 1, 2019

 

 

19,086 

 

 

19,086 

 

 

18,838 

 

3.25%

 

3.25%

Minetta & Orpheum Theatres Loan (USA)

 

November 1, 2023

 

 

8,000 

 

 

8,000 

 

 

7,857 

 

4.88%

 

4.88%

U.S. Corporate Office Term Loan (USA)

 

January 1, 2027

 

 

9,495 

 

 

9,495 

 

 

9,373 

 

4.64% / 4.44%

 

4.61%

Union Square Construction Financing (USA)

 

December 29, 2019

 

 

57,500 

 

 

27,182 

 

 

25,280 

 

6.76% / 12.51%

 

8.35%

Denominated in foreign currency ("FC")(2)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NAB Corporate Loan Facility (AU)

 

December 31, 2023

 

 

46,856 

 

 

37,696 

 

 

37,660 

 

3.05%

 

3.05%

Westpac Corporate Credit Facility (NZ)

 

December 31, 2023

 

 

21,475 

 

 

10,067 

 

 

10,067 

 

3.80%

 

3.80%

Total

 

 

 

$

252,929 

 

$

167,043 

 

$

162,740 

 

 

 

 



(1)

Net of deferred financing costs amounting to $4.3 million.

(2)

The contractual facilities and outstanding balances of the FC-denominated borrowings were translated into U.S. dollar based on exchange rates as of December 31, 2018.

Our loan arrangements are presented, net of the deferred financing costs, on the face of our consolidated balance sheet as follows:







 

 

 

 

 

 



 

 

 

 

 

 

(Dollars in thousands)

 

December 31,

Balance Sheet Caption

 

2019

 

2018

Debt - current portion

 

$

36,736 

 

$

30,393 

Debt - long-term portion

 

 

140,602 

 

 

106,286 

Subordinated debt - current portion

 

 

644 

 

 

 —

Subordinated debt - long-term portion

 

 

29,030 

 

 

26,061 

Total borrowings

 

$

207,012 

 

$

162,740 



Debt denominated in USD



Bank of America Credit Facility



On March 3, 2016, we amended our $55.0 million credit facility with Bank of America to permit real property acquisition loans.  This amendment reduces the applicable consolidated leverage ratio covenant by 0.25% and modifies the term of the facility based on the earlier of the eighteen months from the date of such borrowing or the maturity date of the credit agreement.  Such modification was not considered substantial in accordance with U.S. GAAP. On March 5, 2019, this Credit Facility was extended for six (6) months to May 1, 2020. On August 8, 2019, this Credit Facility was extended by an additional four months to September 1, 2020. On March 6, 2020, we completed the refinancing of this $55.0 million facility, wherein the maturity date was extended to March 6, 2023. The refinanced facility carries an interest rate of 2.5% - 3.0%, depending on certain financial ratios plus a variable rate based on the loan defined “Eurodollar” interest rate. 



Bank of America Line of Credit



In October 2016, the term of this $5.0 million line of credit was extended to October 31, 2019.  Such modification was not considered to be substantial under U.S. GAAP. On August 8, 2019, this Line of Credit was extended an additional ten months to September 1, 2020.  On  March 6, 2020, we completed the refinancing of this Line of Credit, wherein the maturity was extended to March 6, 2023.  



Minetta and Orpheum Theatres Loan



On October 12, 2018, we refinanced our $7.5 million loan with Santander Bank, which is secured by our Minetta and Orpheum Theaters, with a loan for a five year term of $8.0 million. Such modification was not considered to be substantial under U.S. GAAP.



Banc of America Digital Projector Loan



On February 5, 2018, we purchased our U.S. digital cinema projectors, which had previously been held on operating leases, using a $4.6 million loan from Banc of America. We made further U.S. digital cinema projector purchases, of projectors similarly held on other operating leases, in March and April 2018, increasing this loan to $4.9 million. This loan carried an interest rate of 5% and was paid in full on December 28, 2019.



44 Union Square Construction Financing



On December 29, 2016, we closed our new construction finance facilities totaling $57.5 million to fund the non-equity portion of the anticipated construction costs of the redevelopment of our property at 44 Union Square in New York City. The combined facilities consist of $50.0 million in aggregate loans (comprised of three loan tranches) from Bank of the Ozarks (“BOTO”), and a $7.5 million mezzanine loan from Tammany Mezz Investor, LLC, an affiliate of Fisher Brothers.  As of December 31, 2016, BOTO advanced $8.0 million to repay the existing $8.0 million loan with East West Bank. On August 8, 2019, we repaid in full the $7.5 million mezzanine loan from Tammany Mezz Investor, LLC. On January 24, 2020, we exercised the first of our two extension options on the BOTO loan, taking the maturity to December 29, 2020.



Presented in the table below is the breakdown of the 44 Union Square construction financing as of December 31, 2019:







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Dollars in thousands)

 

 

 

Facility Limits and Advances

 

 

 

 

Financing Component

 

Lender

 

Facility
Limit

 

Advanced
-to-Date

 

Remaining
Facility

 

Interest Rate (1)

 

Maturity Date(2)

Senior loan

 

Bank of the Ozarks

 

 

8,000 

 

 

8,000 

 

 

 —

 

Greater of (i) 4.75% and
(ii) Adjusted LIBOR + 4.25%

 

December 29, 2020

Building loan

 

Bank of the Ozarks

 

 

31,130 

 

 

26,236 

 

 

4,894 

 

Greater of (i) 4.75% and
(ii) Adjusted LIBOR + 4.25%

 

December 29, 2020

Project loan

 

Bank of the Ozarks

 

 

10,870 

 

 

1,812 

 

 

9,058 

 

Greater of (i) 4.75% and
(ii) Adjusted LIBOR + 4.25%

 

December 29, 2020

Total 44 Union Square
Financing

 

 

 

$

50,000 

 

$

36,048 

 

$

13,952 

 

 

 

 



(1)

Not to exceed the New York State maximum lawful borrowing rate, which typically is 16%.  

(2)

Allowable for up to two (2) extension request options, one (1) year for each extension request.



U.S. Corporate Office Term Loan



On December 13, 2016, we obtained a ten-year $8.4 million mortgage loan on our new Los Angeles Corporate Headquarters at a fixed annual interest rate of 4.64%.  This loan provided for a second loan upon completion of certain improvements.  On June 26, 2017, we obtained a further $1.5 million under this provision at a fixed annual interest rate of 4.44%.



Cinemas 1,2,3 Term Loan and Line of Credit



On August 31, 2016, Sutton Hill Properties LLC (“SHP”), a 75% subsidiary of RDI, refinanced its $15.0 million Santander Bank term loan with a new lender, Valley National Bank.  This new $20.0 million loan is collateralized by our Cinema 1,2,3 property and bears an interest rate of 3.25% per annum, with principal installments and accruing interest paid monthly. The loan had an option to extend the maturity date for a period of 12 months to March 1, 2021. On March 13, 2020, we refinanced this loan as described in Note 23 – Subsequent Events, with a new term loan of $25.0 million, an interest rate of 4.25%, and maturity date of April 1, 2022 with two six-month options to extend.



Purchase Money Promissory Note



On September 18, 2019, we purchased 407,000 Company shares in a privately negotiated transaction under our Share Repurchase Program for $5.5 million. Of this amount, $3.5 million was paid by the issuance of a Purchase Money Promissory Note, which bears an interest rate of 5.0% per annum, payable in equal quarterly payments of principal plus accrued interest. The Purchase Money Promissory Note matures on September 18, 2024.



Trust Preferred Securities (“TPS”)



On February 5, 2007, we issued $51.5 million in 20-year fully subordinated notes to a trust over which we have significant influence, which in turn issued $51.5 million in securities.  Of the $51.5 million, $50.0 million in TPS were issued to unrelated investors in a private placement and $1.5 million of common trust securities were issued by the trust to Reading called “Investment in Reading International Trust I” on our balance sheets.  Effective May 1, 2012, the interest rate on our Trust Preferred Securities changed from a fixed rate of 9.22%, which was in effect for five years, to a variable rate of three month LIBOR plus 4.00%, which will reset each quarter through the end of the loan unless we exercise our right to re-fix the rate at the current market rate at that time. There are no principal payments due until maturity in 2027 when the notes and the trust securities are scheduled to be paid in full. We may pay off the debt after the first five years at 100% of the principal amount without any penalty. The trust is essentially a pass through, and the transaction is accounted for on our books as the issuance of fully subordinated notes. The credit facility includes a number of affirmative and negative covenants designed to monitor our ability to service the debt. The most restrictive covenant of the facility requires that we must maintain a fixed charge coverage ratio at a certain level. However, on December 31, 2008, we secured a waiver of all financial covenants with respect to our TPS for a period of nine years (through December 31, 2017), in consideration of the payment of $1.6 million, consisting of an initial payment of $1.1 million, a payment of $270,000 made in December 2011, and a payment of $270,000 in December 2014. The covenant waiver expired January 1, 2018, after which a further covenant waiver was secured on October 11, 2018 for the remaining term of the loan, in consideration of payments totaling $1.6 million, consisting of an initial payment of $1.1 million paid on October 31, 2018, and a further contractual obligation to pay $270,000 in October 2021 and $225,000 in October 2025. 



During the first quarter of 2009, we took advantage of the then current market illiquidity for securities such as our TPS to repurchase $22.9 million in face value of those securities through an exchange of $11.5 million worth of marketable securities purchased during the period for the express purpose of executing this exchange transaction with the third party holder of these TPS. During the twelve months ended 2009, we amortized $106,000 of discount to interest income associated with the holding of these securities prior to their extinguishment. On April 30, 2009, we extinguished $22.9 million of these TPS, which resulted in a gain on retirement of subordinated debt (TPS) of $10.7 million net of loss on the associated write-off of deferred loan costs of $749,000 and a reduction in our Investment in Reading International Trust I from $1.5 million to $838,000.



During the three years ended December 31, 2019, we paid $1.4 million in 2017,  $1.6 million in 2018 and $1.8 million in 2019 in preferred dividends to unrelated investors that are included in interest expense. At December 31, 2019 and 2018, we had preferred dividends payable of $272,000 and $299,000, respectively.  Interest payments for this loan are required every three months.



Debt denominated in foreign currencies



Australian NAB Corporate Loan Facility



On March 15, 2019, we amended our Revolving Corporate Markets Loan Facility with National Australia Bank (“NAB”) from a facility comprised of (i) a AU$66.5 million loan facility with an interest rate of 0.95% above the Bank Bill Swap Bid Rate (“BBSY) and a maturity date of June 30, 2019 and (ii) a bank guarantee of AU$5.0 million at a rate of 1.90% per annum into a (i) AU$120.0 million Corporate Loan facility at rates of 0.85%-1.3% above BBSY depending on certain ratios with a due date of December 31, 2023, of which AU$80.0 million is revolving and AU$40.0 million is core and (ii) a Bank Guarantee Facility of AU$5.0 million at a rate of 1.85% per annum. Such modifications of this particular term loan were not considered to be substantial under U.S. GAAP.



New Zealand Westpac Bank Corporate Credit Facility



On December 20, 2018, we restructured our Westpac Corporate Credit Facilities. The maturity of the 1st tranche (general/non-construction credit line) was extended to December 31, 2023, with the available facility being reduced from NZ$35.0 million to NZ$32.0 million. The facility bears an interest rate of 1.75% above the Bank Bill Bid Rate on the drawn down balance and a 1.1% line of credit charge on the entire facility. The 2nd tranche (construction line) with a facility of NZ$18.0 million was removed. 





As of December 31, 2019, our aggregate amount of future principal debt payments is estimated as follows:





 

 

 



 

 

 

(Dollars in thousands)

 

Future
Principal
Debt Payments

2020

 

$

37,380 

2021

 

 

19,150 

2022

 

 

981 

2023

 

 

115,005 

2024

 

 

880 

Thereafter

 

 

35,822 

 Total future principal debt payments

 

$

209,218 



The estimated amount of future principal payments in U.S. dollars is subject to change because the payments in U.S. dollars on the debt denominated in foreign currencies, which represent a significant portion of our total outstanding debt balance, will fluctuate based on the applicable foreign currency exchange rates.